Table 1. Characteristics of male subjects categorized according to fasting plasma glucose.
| MenFasting plasma glucose | Category | |||||
| <100 mg/dL | 100–109 mg/dL | 110–125 mg/dL | 100–125 mg/dL | ≥126 mg/dL | Medication | |
| NFG | High NFG-WHO | IFG-WHO | IFG-ADA | NDD | Known diabetes | |
| Characteristics | N = 726 | N = 208 | N = 136 | N = 344 | N = 92 | N = 47 |
| Age (years) | 59±15 | 61±14 | 61±13 | 61±14 | 67±9**** | 68±9**** |
| Body mass index (kg/m2) | 23.0±3.0 | 24.2±3.1**** | 24.4±3.1**** | 24.3±3.1**** | 24.0±2.9* | 23.4±2.6 |
| Current smoker, % | 39.5 | 31.2* | 33.8 | 32.3* | 21.7*** | 23.4* |
| Current drinker, % | 84.2 | 85.6 | 87.5 | 86.3 | 81.5 | 72.3* |
| History of CVD, % | 9.2 | 9.6 | 12.5 | 10.8 | 10.9 | 19.1* |
| Systolic blood pressure (mmHg) | 135±20 | 145±20**** | 144±20**** | 145±20**** | 146±22**** | 148±21**** |
| Diastolic blood pressure (mmHg) | 82±11 | 86±11**** | 87±12**** | 87±12**** | 85±11 | 85±10 |
| Actual hypertension, % | 20.5 | 31.2*** | 36.0**** | 33.1**** | 31.5* | 48.9**** |
| Total cholesterol (mg/dL) | 188±33 | 198±36**** | 190±37 | 195±36*** | 194±40 | 192±34 |
| HDL cholesterol (mg/dL) | 58±14 | 59±16 | 57±17 | 58±17 | 56±15 | 57±17 |
| Triglycerides (mg/dL) | 96 (71–138) | 107 (77–154) | 112 (79–183)** | 108 (78–162)** | 108 (84–175)* | 92 (67–154) |
| Lipid-lowering medication, % | 3.6 | 4.3 | 3.7 | 4.1 | 3.3 | 14.9*** |
| eGFR (mL/min/1.73 m2) | 80.7±17.4 | 81.1±17.1 | 81.0±18.0 | 81.1±17.4 | 80.8±18.4 | 78.5±19.3 |
| Serum uric acid (mg/dL) | 5.9±1.4 | 6.1±1.5 | 6.2±1.5 | 6.1±1.5 | 5.6±1.5 | 5.6±1.4 |
| Urate-lowering medication, % | 7.7 | 12.0 | 8.8 | 10.8 | 9.8 | 14.9 |
NFG, normal fasting glucose; IFG, impaired fasting glucose, NDD, newly detected diabetes; CVD, cardiovascular disease; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration ratio.
*
P<0.05; **P<0.01; ***P<0.005; ****P<0.001 for comparisons with NFG. Data for triglycerides was skewed, and presented as the median (interquartile range), and log-transformed for analysis.